$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2018 Q1 Form 10-Q Financial Statement

#000156459018011813 Filed on May 08, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $650.1K $8.986M
YoY Change -92.77% 20439.27%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.680M $6.950M
YoY Change -47.05% -33.68%
% of Gross Profit
Research & Development $12.00M $11.44M
YoY Change 4.93% 14.15%
% of Gross Profit
Depreciation & Amortization $1.200M $1.200M
YoY Change 0.0% 50.0%
% of Gross Profit
Operating Expenses $15.68M $15.12M
YoY Change 3.76% -29.06%
Operating Profit -$15.03M -$6.130M
YoY Change 145.27% -71.17%
Interest Expense $168.3K $108.7K
YoY Change 54.81% 37.55%
% of Operating Profit
Other Income/Expense, Net $10.00K
YoY Change -97.77%
Pretax Income -$14.88M -$6.040M
YoY Change 146.36% -70.98%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$14.88M -$6.043M
YoY Change 146.32% -70.97%
Net Earnings / Revenue -2289.45% -67.24%
Basic Earnings Per Share -$0.18
Diluted Earnings Per Share -$0.18 -$80.93K
COMMON SHARES
Basic Shares Outstanding 84.08M 74.57M
Diluted Shares Outstanding 84.08M

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $91.50M $86.60M
YoY Change 5.66% 40.81%
Cash & Equivalents $69.80M $61.72M
Short-Term Investments $21.70M $24.90M
Other Short-Term Assets $1.100M $2.400M
YoY Change -54.17% -48.94%
Inventory
Prepaid Expenses
Receivables $0.00 $600.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $92.70M $89.70M
YoY Change 3.34% 35.7%
LONG-TERM ASSETS
Property, Plant & Equipment $14.60M $15.70M
YoY Change -7.01% 256.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $200.0K
YoY Change -50.0% 100.0%
Total Long-Term Assets $34.30M $37.20M
YoY Change -7.8% 30.53%
TOTAL ASSETS
Total Short-Term Assets $92.70M $89.70M
Total Long-Term Assets $34.30M $37.20M
Total Assets $127.0M $126.9M
YoY Change 0.08% 34.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.800M $2.600M
YoY Change -30.77% -65.33%
Accrued Expenses $5.000M $3.000M
YoY Change 66.67% -42.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $200.0K
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $9.100M $27.60M
YoY Change -67.03% 95.74%
LONG-TERM LIABILITIES
Long-Term Debt $2.200M $2.400M
YoY Change -8.33% 500.0%
Other Long-Term Liabilities $1.900M $3.600M
YoY Change -47.22% -41.94%
Total Long-Term Liabilities $4.100M $6.000M
YoY Change -31.67% -9.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.100M $27.60M
Total Long-Term Liabilities $4.100M $6.000M
Total Liabilities $12.70M $33.00M
YoY Change -61.52% 64.18%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $114.3M $93.90M
YoY Change
Total Liabilities & Shareholders Equity $127.0M $126.9M
YoY Change 0.08% 34.14%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$14.88M -$6.043M
YoY Change 146.32% -70.97%
Depreciation, Depletion And Amortization $1.200M $1.200M
YoY Change 0.0% 50.0%
Cash From Operating Activities -$15.40M -$14.30M
YoY Change 7.69% -3.38%
INVESTING ACTIVITIES
Capital Expenditures -$400.0K -$1.400M
YoY Change -71.43% 1300.0%
Acquisitions
YoY Change
Other Investing Activities $17.20M -$24.80M
YoY Change -169.35% -875.0%
Cash From Investing Activities $16.80M -$26.20M
YoY Change -164.12% -945.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 56.90M 200.0K
YoY Change 28350.0% -200.0%
NET CHANGE
Cash From Operating Activities -15.40M -14.30M
Cash From Investing Activities 16.80M -26.20M
Cash From Financing Activities 56.90M 200.0K
Net Change In Cash 58.30M -40.30M
YoY Change -244.67% 238.66%
FREE CASH FLOW
Cash From Operating Activities -$15.40M -$14.30M
Capital Expenditures -$400.0K -$1.400M
Free Cash Flow -$15.00M -$12.90M
YoY Change 16.28% -12.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
141918
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15513019
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20464439
CY2017Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
40769539
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
24921972
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
26226466
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3677356
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8085381
CY2017Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
440580
CY2018Q1 us-gaap Revenues
Revenues
650125
CY2017Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
11438216
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
15684184
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
15115572
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-15034059
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6129642
us-gaap Operating Income Loss
OperatingIncomeLoss
-28847407
CY2018Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
168346
CY2017Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
108744
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
332077
CY2017Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
2325018
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87570398
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87570398
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8156491
us-gaap Operating Expenses
OperatingExpenses
34382957
us-gaap Operating Income Loss
OperatingIncomeLoss
-21031531
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
133892
us-gaap Share Based Compensation
ShareBasedCompensation
4168673
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2373255
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
64387
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
505825
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2524107
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4988620
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5415933
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-139452
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6653158
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3681830
us-gaap Operating Expenses
OperatingExpenses
33007353
CY2018Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-18598
CY2017Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-27383
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1312524
us-gaap Profit Loss
ProfitLoss
-28083189
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
74629855
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79406838
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1561
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
154464
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7967
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14882750
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5888093
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28091156
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3549354
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
193125
arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
666230
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-54668
CY2018Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.25
us-gaap Share Based Compensation
ShareBasedCompensation
3549354
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2294639
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-346339
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-51510
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1225562
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3704740
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
17307431
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2266082
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2918752
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-196434
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-30133934
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4325866
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
513719
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5018040
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
24846105
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
23704420
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
18172661
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-31499263
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
102406
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
97145
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
54667
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
417140
arwr Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
499861
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56585035
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12691937
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
56927823
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
12177652
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
44966550
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-23647477
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85366448
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61718971
us-gaap Interest Paid
InterestPaid
88537
us-gaap Interest Paid
InterestPaid
95544
arwr Proceeds From Refundable Income Tax Credits
ProceedsFromRefundableIncomeTaxCredits
3635016
us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Concentration of Credit Risk&#8212;The Company maintains several bank accounts at two financial institutions for its operations. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per institution. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. </p></div>
CY2018Q1 arwr Finite Lived Intangible Assets Amortization Expense After Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearSix
10261864
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
arwr Increase Decrease In Cash And Investments
IncreaseDecreaseInCashAndInvestments
25900000
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2018Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2017Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2018Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
600334
CY2017Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
600334
CY2018Q1 arwr Research Equipment
ResearchEquipment
10174679
CY2017Q3 arwr Research Equipment
ResearchEquipment
9660960
CY2018Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
132078
CY2017Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
132078
CY2018Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
12208380
CY2017Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
12208380
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23115471
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22601752
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8533158
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7088733
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
850215
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
850215
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
425107
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
425107
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
850215
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700429
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700429
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700429
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700429
CY2018Q1 arwr Finite Lived Intangible Assets Amortization Expense Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseYearSix
1700429
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5549543
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8190872
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.021
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13719627
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
80000
CY2018Q1 arwr Facility Rent Expense
FacilityRentExpense
304700
CY2017Q1 arwr Facility Rent Expense
FacilityRentExpense
416800
arwr Facility Rent Expense
FacilityRentExpense
630300
arwr Facility Rent Expense
FacilityRentExpense
797900
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
767651
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1435409
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1044431
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1070496
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1097168
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4669328
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
10084483
CY2018Q1 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
106100
CY2018Q1 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
223820
CY2018Q1 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
240258
CY2018Q1 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
257903
CY2018Q1 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
276845
CY2018Q1 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
1326192
CY2018Q1 us-gaap Contractual Obligation
ContractualObligation
2431118
CY2018Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2018Q1 us-gaap Purchase Obligation
PurchaseObligation
23500000
CY2018Q1 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
13500000
CY2018Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
10000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
660000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
124678
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
79374
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6005491
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4244466
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.00
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.12
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.33
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.43
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.80
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.013
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.027
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.021
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.36
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
At vesting, each outstanding RSU will be exchanged for one share of the Company’s Common Stock. RSU recipients may elect to net share settle upon vesting, in which case the Company pays the employee’s income taxes due upon vesting and withholds a number of shares of Common Stock of equal value. RSU awards generally vest subject to the satisfaction of service requirements or the satisfaction of both service requirements and achievement of certain performance targets.

Files In Submission

Name View Source Status
0001564590-18-011813-index-headers.html Edgar Link pending
0001564590-18-011813-index.html Edgar Link pending
0001564590-18-011813.txt Edgar Link pending
0001564590-18-011813-xbrl.zip Edgar Link pending
arwr-10q_20180331.htm Edgar Link pending
arwr-20180331.xml Edgar Link completed
arwr-20180331.xsd Edgar Link pending
arwr-20180331_cal.xml Edgar Link unprocessable
arwr-20180331_def.xml Edgar Link unprocessable
arwr-20180331_lab.xml Edgar Link unprocessable
arwr-20180331_pre.xml Edgar Link unprocessable
arwr-ex311_9.htm Edgar Link pending
arwr-ex312_8.htm Edgar Link pending
arwr-ex321_7.htm Edgar Link pending
arwr-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending